tlooto
Sign up
SCIESCOPUSQ1

Communications Medicine

SPRINGERNATURE, United Kingdom

Communications Medicine is an academic journal published by SPRINGERNATURE (United Kingdom). Identifiers: ISSN 2730-664X, eISSN 2730-664X. Indexed in SCIE, SCOPUS. Metrics: JIF 6.3, CiteScore 6.6, SJR 2.098, SNIP 1.39. Subject areas: MEDICINE, RESEARCH & EXPERIMENTAL. tlooto lists 2,600 papers from this journal.

CiteScore

6.60

Scopus citation metric

SJR

2.098

SCImago rank

SNIP

1.39

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
2730-664X
eISSN
2730-664X
Abbreviation
COMMUN MED-LONDON
Publisher
SPRINGERNATURE
Country
United Kingdom

Web of Science categories

No Web of Science category data available.

Scopus ASJC categories

2701 Medicine (miscellaneous)2713 Epidemiology2724 Internal Medicine2739 Public Health2903 Assessment and Diagnosis

Papers in this journal

Recent papers

  1. Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera

    2026

  2. Exploring donor-derived cell-free DNA as a rejection biomarker during uterus transplant follow up.

    2026

  3. Genomic characterization and sub-clustering of Escherichia coli clonal complex 38 reveal host associated genetic markers

    2026

  4. A study of the associations between social isolation and loneliness with sex-specific cancer risk in the UK Biobank

    2026

  5. Sequential versus upfront oxaliplatin-based therapy in metastatic colorectal cancer: long-term outcomes of a randomized phase 3 trial.

    2026

Most cited papers

  1. The future landscape of large language models in medicine

    2023 · 932 citations

  2. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

    2022 · 245 citations

  3. Mitigating bias in machine learning for medicine

    2021 · 228 citations

  4. Current applications and challenges in large language models for patient care: a systematic review

    2025 · 223 citations

  5. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

    2024 · 207 citations